Revenue
$29.73B
Gross Margin
+79.4%
Operating Margin
+38.3%
Net Margin
+31.0%
Income statement waterfall for Gilead Sciences (GILD) — TTM through Q1 2026
Net income: $9.22B
Margin breakdown for Gilead Sciences (GILD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $29.73B | $29.73B |
| Cost of Revenue | −$6.14B | $23.59B |
| Gross Profit | $23.59B | $23.59B |
| Operating Expenses | −$12.22B | $11.38B |
| Operating Income | $11.38B | $11.38B |
| Other Income / Expense | −$647.00M | $10.73B |
| Pre-tax Income | $10.73B | $10.73B |
| Income Tax | −$1.51B | $9.22B |
| Net Income | $9.22B | $9.22B |
- Revenue$29.73B
- Cost of Revenue−$6.14B
- Gross Profit$23.59B
- Operating Expenses−$12.22B
- Operating Income$11.38B
- Other Income / Expense−$647.00M
- Pre-tax Income$10.73B
- Income Tax−$1.51B
- Net Income$9.22B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement